Riederer P, Horowski R
J Neural Transm (Vienna). 2023; 130(11):1323-1335.
PMID: 37796288
PMC: 10645634.
DOI: 10.1007/s00702-023-02692-9.
Fahn S
Mov Disord Clin Pract. 2021; 8(7):993-996.
PMID: 34631934
PMC: 8485602.
DOI: 10.1002/mdc3.13337.
Borgonovo J, Ahumada-Galleguillos P, Onate-Ponce A, Allende-Castro C, Henny P, Concha M
Front Neuroanat. 2021; 15:728720.
PMID: 34588961
PMC: 8473916.
DOI: 10.3389/fnana.2021.728720.
Gopinath A, Badov M, Francis M, Shaw G, Collins A, Miller D
NPJ Parkinsons Dis. 2021; 7(1):62.
PMID: 34285243
PMC: 8292430.
DOI: 10.1038/s41531-021-00201-x.
Matt S, Gaskill P
J Neuroimmune Pharmacol. 2019; 15(1):114-164.
PMID: 31077015
PMC: 6842680.
DOI: 10.1007/s11481-019-09851-4.
Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortex.
Cathel A, Reyes B, Wang Q, Palma J, Mackie K, Van Bockstaele E
Eur J Neurosci. 2014; 40(8):3202-14.
PMID: 25131562
PMC: 4205194.
DOI: 10.1111/ejn.12690.
Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.
Smith Y, Wichmann T, Factor S, DeLong M
Neuropsychopharmacology. 2011; 37(1):213-46.
PMID: 21956442
PMC: 3238085.
DOI: 10.1038/npp.2011.212.
Occurrence of dopamine and noradrenaline in the nervous tissue of some invertebrate species.
Cottrell G
Br J Pharmacol Chemother. 2008; 29(1):63-9.
PMID: 19108240
PMC: 1557178.
DOI: 10.1111/j.1476-5381.1967.tb01939.x.
Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action.
Olijslagers J, Werkman T, McCreary A, Kruse C, Wadman W
Curr Neuropharmacol. 2008; 4(1):59-68.
PMID: 18615139
PMC: 2430681.
DOI: 10.2174/157015906775203020.
Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury.
Yan H, Ma X, Chen X, Li Y, Shao L, Dixon C
Brain Res. 2007; 1134(1):171-9.
PMID: 17196177
PMC: 4017583.
DOI: 10.1016/j.brainres.2006.11.087.
Imaging in cell-based therapy for neurodegenerative diseases.
Kirik D, Breysse N, Bjorklund T, Besret L, Hantraye P
Eur J Nucl Med Mol Imaging. 2005; 32 Suppl 2:S417-34.
PMID: 16267643
DOI: 10.1007/s00259-005-1909-6.
THE ESTIMATION OF SMALL QUANTITIES OF 3,4-DIHYDROXYPHENYLETHYLAMINE IN TISSUES.
Laverty R, SHARMAN D
Br J Pharmacol Chemother. 1965; 24:538-48.
PMID: 14320868
PMC: 1704139.
DOI: 10.1111/j.1476-5381.1965.tb01744.x.
OBSERVATIONS ON THE CELLULAR LOCALIZATION OF DOPAMINE IN THE CAUDATE NUCLEUS OF THE RAT.
Fuxe K, HOEKFELT T, Nilsson O
Z Zellforsch Mikrosk Anat. 1964; 63:701-6.
PMID: 14254762
DOI: 10.1007/BF00339917.
THE SUBCELLULAR LOCALIZATION OF DOPAMINE AND ACETYLCHOLINE IN THE DOG CAUDATE NUCLEUS.
Laverty R, MICHAELSON I, SHARMAN D, Whittaker V
Br J Pharmacol Chemother. 1963; 21:482-90.
PMID: 14110748
PMC: 1703886.
DOI: 10.1111/j.1476-5381.1963.tb02016.x.
OBSERVATIONS ON THE INHIBITION OF HISTAMINE FORMATION.
KAHLSON G, ROSENGREN E, THUNBERG R
J Physiol. 1963; 169:467-86.
PMID: 14082112
PMC: 1368714.
DOI: 10.1113/jphysiol.1963.sp007273.
TEMPORARY AND PARTIAL ANTAGONISM BY L-DOPA OF RESERPINE-INDUCED SUPPRESSION OF A CONDITIONED AVOIDANCE RESPONSE.
Seiden L, Carlsson A
Psychopharmacologia. 1963; 4:418-23.
PMID: 14048562
DOI: 10.1007/BF00403346.
Actions of certain amines on cerebral cortical neurones.
Krnjevic K, Phillis J
Br J Pharmacol Chemother. 1963; 20:471-90.
PMID: 14035890
PMC: 1703804.
DOI: 10.1111/j.1476-5381.1963.tb01484.x.
Topographical differences in the cerebral metabolism of DL-2-14C-3,4-dihydroxphenylalanine.
Pletscher A, GEY K
Experientia. 1962; 18:512-3.
PMID: 13944046
DOI: 10.1007/BF02151603.
The distribution of adenosine triphosphate in subcellular fractions of brain tissue.
Nyman M, Whittaker V
Biochem J. 1963; 87:248-55.
PMID: 13939322
PMC: 1201883.
DOI: 10.1042/bj0870248.
Cholinergic and non-cholinergic transmission in the mammalian spinal cord.
Curtis D, Phillis J, Watkins J
J Physiol. 1961; 158:296-323.
PMID: 13882769
PMC: 1359968.
DOI: 10.1113/jphysiol.1961.sp006770.
